marketcap
Facebook
X
TelegramAphria Inc. Gesamtverbindlichkeiten 2011-2025 | APHA
Gesamtverbindlichkeiten Jährlich Aphria Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 660 M | 708 M | 140 M | 42.1 M | 1.27 M | 947 K | 30 K | 11 K | 11 K | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 708 M | 11 K | 173 M |
Gesamtverbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Graybug Vision
GRAY
|
4.03 M | $ 0.44 | -11.23 % | $ 9.65 M |  USA |
 |
AgeX Therapeutics
AGE
|
6.61 M | $ 11.3 | -10.17 % | $ 12.2 K | - |
 |
Galera Therapeutics
GRTX
|
154 M | $ 0.14 | -32.59 % | $ 7.61 M | USA |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
49.9 M | $ 4.37 | -1.58 % | $ 28.1 M |  China |
 |
Axon Enterprise
AXON
|
2.15 B | $ 598.26 | -6.45 % | $ 45.3 B | USA |
 |
Caladrius Biosciences
CLBS
|
5.68 M | $ 0.43 | -16.75 % | $ 25.8 M | USA |
 |
Sorrento Therapeutics
SRNE
|
617 M | $ 0.27 | -29.58 % | $ 126 M | USA |
 |
BeiGene, Ltd.
BGNE
|
2.59 B | $ 184.71 | 0.49 % | $ 251 B |  Cayman-islands |
 |
ContraFect Corporation
CFRX
|
32.5 M | $ 1.47 | -5.16 % | $ 5.39 M | USA |
 |
Orchard Therapeutics plc
ORTX
|
121 M | $ 4.93 | 1.02 % | $ 90.8 M |  Britain |
 |
Midatech Pharma plc
MTP
|
6.46 M | $ 0.29 | -18.52 % | $ 27.3 M | Britain |
 |
Advaxis
ADXS
|
7.89 M | $ 0.31 | -9.65 % | $ 45.9 M | USA |
 |
Heat Biologics, Inc.
HTBX
|
8.7 M | $ 3.93 | -5.76 % | $ 99.8 M | USA |
 |
La Jolla Pharmaceutical Company
LJPC
|
168 M | $ 6.2 | - | $ 154 M | USA |
 |
Zymeworks
ZYME
|
140 M | $ 6.42 | - | $ 404 M |  Canada |
 |
Aeterna Zentaris
AEZS
|
21.9 M | $ 5.72 | 5.93 % | $ 314 M | Canada |
 |
Checkmate Pharmaceuticals
CMPI
|
9.38 M | $ 10.5 | - | $ 231 M | USA |
 |
Kadmon Holdings, Inc.
KDMN
|
46.7 M | $ 9.5 | - | $ 1.7 B | USA |
 |
BioDelivery Sciences International
BDSI
|
137 M | $ 2.58 | -4.8 % | $ 255 M | USA |
 |
Zosano Pharma Corporation
ZSAN
|
15.4 M | $ 0.56 | 7.23 % | $ 2.72 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
7.43 M | $ 0.5 | - | $ 7.46 M |  Israel |
 |
Kiromic BioPharma
KRBP
|
21.1 M | $ 3.15 | 6.61 % | $ 3.08 M | USA |
 |
Acceleron Pharma Inc.
XLRN
|
77.2 M | $ 179.68 | - | $ 10.9 B | USA |
 |
Albireo Pharma
ALBO
|
126 M | $ 44.15 | -0.23 % | $ 916 M | USA |
 |
Stealth BioTherapeutics Corp
MITO
|
95.5 M | $ 0.32 | - | $ 23.9 M | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
22 M | $ 18.44 | - | $ 1.94 B | Canada |
 |
Kaleido Biosciences
KLDO
|
39.5 M | $ 0.29 | -3.69 % | $ 12.4 M | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
9.71 M | $ 2.19 | - | $ 105 M | USA |
 |
CureVac N.V.
CVAC
|
470 M | $ 5.25 | -0.38 % | $ 977 M |  Germany |
 |
Humanigen
HGEN
|
58 M | $ 0.04 | -81.12 % | $ 4.28 M | USA |
 |
Aptinyx
APTX
|
28.4 M | $ 0.06 | -39.0 % | $ 4.57 M | USA |
 |
Tyme Technologies
TYME
|
8.47 M | $ 0.31 | 8.07 % | $ 54 M | USA |
 |
Evogene Ltd.
EVGN
|
25 M | $ 1.16 | -1.69 % | $ 27.9 M | Israel |
 |
Forward Pharma A/S
FWP
|
1.07 M | $ 2.64 | -0.75 % | $ 18.7 M |  Danmark |
 |
Applied Genetic Technologies Corporation
AGTC
|
37.2 M | $ 0.39 | - | $ 26.5 M | USA |
 |
Celyad Oncology SA
CYAD
|
35.1 M | $ 0.47 | - | $ 12.5 M |  Belgium |
 |
Brickell Biotech
BBI
|
6.5 M | $ 2.11 | -5.38 % | $ 6.06 M | USA |
 |
Genocea Biosciences
GNCA
|
28.9 M | $ 0.05 | -15.0 % | $ 3.04 M | USA |
 |
Codiak BioSciences
CDAK
|
118 M | $ 0.06 | -55.98 % | $ 2.15 M | USA |
 |
FibroGen
FGEN
|
586 M | $ 11.04 | 0.33 % | $ 1.07 B | USA |
 |
Concert Pharmaceuticals
CNCE
|
53.1 M | $ 8.37 | - | $ 401 M | USA |
 |
AIkido Pharma
AIKI
|
7.27 M | $ 3.17 | 1.93 % | $ 17.4 M | USA |
 |
Cyclerion Therapeutics
CYCN
|
55.9 M | $ 1.74 | -0.63 % | $ 4.38 M | USA |
 |
Calithera Biosciences
CALA
|
15.7 M | $ 0.37 | -10.95 % | $ 876 K | USA |
 |
Forma Therapeutics Holdings
FMTX
|
62.7 M | $ 20.01 | - | $ 958 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
110 M | $ 49.55 | -6.81 % | $ 3.04 B | USA |
 |
Sierra Oncology
SRRA
|
13.4 M | $ 54.89 | -0.05 % | $ 1.34 B | Canada |
 |
Regulus Therapeutics
RGLS
|
9.56 M | $ 8.16 | - | $ 155 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
1.1 B | - | - | - |  Russia |
|
Yunhong International
ZGYH
|
2.94 M | $ 10.31 | 0.10 % | $ 92.2 M | China |